Spike: wearable technology
Spikenergy and SpikeCell products are the result of the most advanced research in textile materials.
The innovation lies in the possibility to treat inflammation, oedema and acute and chronic pain with a wearable device.
Clinically tested and patented in 28 countries
Working under the supervision of a pool of experts, we have succeeded in creating Spike, a fabric woven with zinc, copper and silicon fibres whose unique composition relieves pain and reduces healing time by exerting constant biostimulation aimed at restoring microcirculation.
How does it work?
Spike is a polyester yarn in which silicon, copper and zinc fibres are incorporated.
Thanks to body heat, these minerals are activated, producing a microcurrent that penetrates the skin and subcutaneous layers, facilitating muscle relaxation and improving microcirculation and drainage of excess fluid.
A completely natural process that is also activated in cases of pain, becoming a valuable ally to help treat osteo-articular problems, oedemas and poor circulation.
In recent years, the medical world is witnessing an increasing interest in alternative bioenergetic therapeutic approaches, capable of assisting or replacing pharmacological therapies. Recent studies have shown that using microcurrent bands promotes the restoration and recovery of normal cellular functions, helping to heal trauma, inflammation, oedema and various degenerative and overload conditions.
An innovative textile product that generates a microcurrent with therapeutic properties for the treatment of venous insufficiency. Bandages have been used for support and compression since time immemorial, so much so that the first records date back to the Neolithic period (5,000 to 2,500 BC), with finds of paintings in the Tassili caves of the Sahara depicting leg-bandaged warriors performing a kind of ritual dance. Bandages were increasingly used in medicine over the following centuries, and were produced in various fibrous materials, such as wool, linen, rubber, and so on. However, the first modern application of elastic compressive bandages came after 1850 with the production of elastic fabrics, and much later elastic stockings.
Electromagnetic therapy has traditionally been considered an alternative discipline, although, in reality, it now shares the same aims and premises as the medical-biological sciences according to evidence reported in the literature and data from recent experimental studies. Starting from the hypothesis of using the properties of metals to treat certain functional alterations of the body, a fabric was created from copper, zinc and silicon fibres, giving the product unique, innovative qualities. To bring scientific rigour and relevance to a discipline that has been, thus far, almost exclusively empirical, the product has been subjected to a series of precise clinical assessments aimed at objectively evaluating the benefits for specific body areas (skin and joints) and highlighting the mechanism of action of creating a sort of Voltaic pile from the physical association of the three fibres. The communication will detail the safety and efficacy aspects investigated.
Lateral ankle sprains are among the most common injuries during athletic or recreational activities. In particular, around 260,000 ankle sprains are recorded per year in the United Kingdom, and more than 23,000 in the United States per day, accounting for costs of approximately 2 billion US dollars per year. Around 40% of sprains can cause chronic complications, therefore, underestimating such trauma can lead to long-term discomfort for patients. Aimed at speeding-up recovery and helping patients return to normal daily activities after an ankle sprain, we designed a randomized double-blind study to prove the validity of the conservative treatment for acute first and second degree ankle sprains using Spikenergy ankle supports vs. normal elastic ankle supports over a short period.
The results after
two weeks of use
Several clinical studies have been conducted to verify the benefits of microcurrent therapy with Spike fabric, including one conducted in collaboration with LYNN A. WALLACE, which showed that 94% of 1531 patients with acute musculoskeletal injuries experienced a reduction in pain during the first treatment without any side effects or aggravation of symptoms.
The test was carried out using techniques designed to eliminate possible placebo effects.